A research team led by Albert Einstein College of Medicine scientists has developed a new strategy to engineer immune cells that dramatically prolongs their effectiveness after being infused into ...
By simulating the life cycle of a minimal bacterial cell—from DNA replication to protein translation to metabolism and cell ...
Sanofi has struck an exclusive rights deal with Dutch biotech Kiadis focused on combining modified natural killer cells with the French pharma’s blood cancer antibody Sarclisa. Sarclisa (isatuximab) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results